Bafna Pharmaceuticals
BSE: 532989|NSE: BAFNAPHARM|ISIN: INE878I01014|SECTOR: Pharmaceuticals
LIVE
BSE
May 22, 10:12
37.00
-0.4 (-1.07%)VOLUME 4,084
LIVE
NSE
May 22, 10:11
37.10
-0.35 (-0.93%) VOLUME 5,579
Business News on Bafna Pharmaceuticals
Bafna Pharmaceuticals gets nod from Ghana for Omeran-20
4.10 pm | 03 May 2013 | Source: PTI
Bafna Pharmaceuticals has received approval from Ghana to market Omeran-20 capsules used for the treatment of reflux oesophagitis among others....
1
Quick Links for Bafna Pharmaceuticals
Related Searches
Bafna Pharmaceuticals Stock Price, Bafna Pharma Stock Quote, Bafna Pharma Results , Bafna Pharma News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget
| Financial Glossary
|
Message Board |
Moneybhai |
India's Premiere Technology Guide |
History India | Davos
| Tech Mahindra Limited | Mining | P. Chidambaram | Haryana | Indian rupee | Apple Inc. | Goldman Sachs Group | Inc. (The) 6.125% Notes due 2060 | Petrapole | Taxes | Phaneesh Murthy
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.